Literature DB >> 2611035

Hyponatraemia following cisplatin chemotherapy.

D Bissett1, E J Cornford, M Sokal.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2611035     DOI： 10.3109/02841868909092315

Source DB:  PubMed          Journal:  Acta Oncol        ISSN： 0284-186X            Impact factor:   4.089


× No keyword cloud information.
  4 in total

1.  Hyponatraemia is a predictor of clinical outcome for malignant pleural mesothelioma.

Authors:  R Berardi; M Caramanti; I Fiordoliva; F Morgese; A Savini; S Rinaldi; M Torniai; M Tiberi; C Ferrini; M Castagnani; F Rovinelli; A Onofri; S Cascinu
Journal:  Support Care Cancer       Date:  2014-08-21       Impact factor: 3.603

Review 2.  Hyponatremia related to medical anticancer treatment.

Authors:  T Berghmans
Journal:  Support Care Cancer       Date:  1996-09       Impact factor: 3.603

Review 3.  Diagnosis and management of hyponatremia in cancer patients.

Authors:  Harry Raftopoulos
Journal:  Support Care Cancer       Date:  2007-08-14       Impact factor: 3.603

4.  Renal Salt-Wasting Syndrome Induced by Neoadjuvant Chemotherapy Containing Cisplatin - A Case Report.

Authors:  N Jinsi; A Vimala; Sreeja S Nair; R Arya; Ranjani Ravi
Journal:  Indian J Nephrol       Date:  2021-12-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.